請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/85564完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林翰佑 | zh_TW |
| dc.contributor.advisor | Han-You Lin | en |
| dc.contributor.author | 張皓鈞 | zh_TW |
| dc.contributor.author | Hao-Chun Chang | en |
| dc.date.accessioned | 2023-03-19T23:18:41Z | - |
| dc.date.available | 2023-12-26 | - |
| dc.date.copyright | 2022-07-08 | - |
| dc.date.issued | 2022 | - |
| dc.date.submitted | 2002-01-01 | - |
| dc.identifier.citation | [1] S. Rose-John, K. Winthrop, L. Calabrese, The role of IL-6 in host defence against infections: immunobiology and clinical implications, Nat Rev Rheumatol 13(7) (2017) 399-409. [2] T. Hirano, K. Yasukawa, H. Harada, T. Taga, Y. Watanabe, T. Matsuda, S.-i. Kashiwamura, K. Nakajima, K. Koyama, A. Iwamatsu, S. Tsunasawa, F. Sakiyama, H. Matsui, Y. Takahara, T. Taniguchi, T. Kishimoto, Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin, Nature 324(6092) (1986) 73-76. [3] M.J. Boulanger, D.C. Chow, E.E. Brevnova, K.C. Garcia, Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex, Science 300(5628) (2003) 2101-4. [4] D.E. Johnson, R.A. O'Keefe, J.R. Grandis, Targeting the IL-6/JAK/STAT3 signalling axis in cancer, Nat Rev Clin Oncol 15(4) (2018) 234-248. [5] K. Taniguchi, L.W. Wu, S.I. Grivennikov, P.R. de Jong, I. Lian, F.X. Yu, K. Wang, S.B. Ho, B.S. Boland, J.T. Chang, W.J. Sandborn, G. Hardiman, E. Raz, Y. Maehara, A. Yoshimura, J. Zucman-Rossi, K.L. Guan, M. Karin, A gp130-Src-YAP module links inflammation to epithelial regeneration, Nature 519(7541) (2015) 57-62. [6] C.A. Hunter, S.A. Jones, IL-6 as a keystone cytokine in health and disease, Nat Immunol 16(5) (2015) 448-57. [7] L.H. Calabrese, S. Rose-John, IL-6 biology: implications for clinical targeting in rheumatic disease, Nat Rev Rheumatol 10(12) (2014) 720-7. [8] M. Norelli, B. Camisa, G. Barbiera, L. Falcone, A. Purevdorj, M. Genua, F. Sanvito, M. Ponzoni, C. Doglioni, P. Cristofori, C. Traversari, C. Bordignon, F. Ciceri, R. Ostuni, C. Bonini, M. Casucci, A. Bondanza, Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells, Nat Med 24(6) (2018) 739-748. [9] S.A. Jones, C.A. Hunter, Is IL-6 a key cytokine target for therapy in COVID-19?, Nat Rev Immunol 21(6) (2021) 337-339. [10] D.M. Del Valle, S. Kim-Schulze, H.H. Huang, N.D. Beckmann, S. Nirenberg, B. Wang, Y. Lavin, T.H. Swartz, D. Madduri, A. Stock, T.U. Marron, H. Xie, M. Patel, K. Tuballes, O. Van Oekelen, A. Rahman, P. Kovatch, J.A. Aberg, E. Schadt, S. Jagannath, M. Mazumdar, A.W. Charney, A. Firpo-Betancourt, D.R. Mendu, J. Jhang, D. Reich, K. Sigel, C. Cordon-Cardo, M. Feldmann, S. Parekh, M. Merad, S. Gnjatic, An inflammatory cytokine signature predicts COVID-19 severity and survival, Nat Med 26(10) (2020) 1636-1643. [11] M.S. Diamond, T.D. Kanneganti, Innate immunity: the first line of defense against SARS-CoV-2, Nat Immunol 23(2) (2022) 165-176. [12] M. Fischer, J. Goldschmitt, C. Peschel, J.P. Brakenhoff, K.J. Kallen, A. Wollmer, J. Grotzinger, S. Rose-John, I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion, Nat Biotechnol 15(2) (1997) 142-5. [13] S. Bird, J. Zou, R. Savan, T. Kono, M. Sakai, J. Woo, C. Secombes, Characterisation and expression analysis of an interleukin 6 homologue in the Japanese pufferfish, Fugu rubripes, Dev Comp Immunol 29(9) (2005) 775-89. [14] D.B. Iliev, B. Castellana, S. Mackenzie, J.V. Planas, F.W. Goetz, Cloning and expression analysis of an IL-6 homolog in rainbow trout (Oncorhynchus mykiss), Mol Immunol 44(7) (2007) 1803-7. [15] Q. Zhu, C. Li, Z.X. Yu, P.F. Zou, Q.X. Meng, C.L. Yao, Molecular and immune response characterizations of IL-6 in large yellow croaker (Larimichthys crocea), Fish Shellfish Immunol 50 (2016) 263-73. [16] H.H. Chen, H.T. Lin, Y.F. Foung, J. Han-You Lin, The bioactivity of teleost IL-6: IL-6 protein in orange-spotted grouper (Epinephelus coioides) induces Th2 cell differentiation pathway and antibody production, Dev Comp Immunol 38(2) (2012) 285-94. [17] M. Kaneda, T. Odaka, H. Suetake, D. Tahara, T. Miyadai, Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130, Dev Comp Immunol 38(2) (2012) 224-31. [18] 方苡帆, 應用重組介白素-6於點帶石斑魚之抗病機轉研究, 生物科技研究所碩博士班, 國立成功大學, 台南市, 2013, p. 102. [19] 陳俊翰, 不同給藥路徑給予介白素-6對點帶石斑魚免疫能力促進之評估, 生物科技研究所, 國立成功大學, 台南市, 2015, p. 100. [20] J.A. Lust, K.A. Donovan, M.P. Kline, P.R. Greipp, R.A. Kyle, N.J. Maihle, Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor, Cytokine 4(2) (1992) 96-100. [21] S. Riethmueller, P. Somasundaram, J.C. Ehlers, C.W. Hung, C.M. Flynn, J. Lokau, M. Agthe, S. Dusterhoft, Y. Zhu, J. Grotzinger, I. Lorenzen, T. Koudelka, K. Yamamoto, U. Pickhinke, R. Wichert, C. Becker-Pauly, M. Radisch, A. Albrecht, M. Hessefort, D. Stahnke, C. Unverzagt, S. Rose-John, A. Tholey, C. Garbers, Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation, PLoS Biol 15(1) (2017) e2000080. [22] S. Heink, N. Yogev, C. Garbers, M. Herwerth, L. Aly, C. Gasperi, V. Husterer, A.L. Croxford, K. Moller-Hackbarth, H.S. Bartsch, K. Sotlar, S. Krebs, T. Regen, H. Blum, B. Hemmer, T. Misgeld, T.F. Wunderlich, J. Hidalgo, M. Oukka, S. Rose-John, M. Schmidt-Supprian, A. Waisman, T. Korn, Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells, Nat Immunol 18(1) (2017) 74-85. [23] S. Rose-John, P.C. Heinrich, Soluble receptors for cytokines and growth factors: generation and biological function, Biochem J 300 ( Pt 2) (1994) 281-90. [24] C. Garbers, S. Heink, T. Korn, S. Rose-John, Interleukin-6: designing specific therapeutics for a complex cytokine, Nat Rev Drug Discov 17(6) (2018) 395-412. [25] E.H. Choy, F. De Benedetti, T. Takeuchi, M. Hashizume, M.R. John, T. Kishimoto, Translating IL-6 biology into effective treatments, Nat Rev Rheumatol 16(6) (2020) 335-345. [26] S. Hong, R. Li, Q. Xu, C.J. Secombes, T. Wang, Two types of TNF-alpha exist in teleost fish: phylogeny, expression, and bioactivity analysis of type-II TNF-alpha3 in rainbow trout Oncorhynchus mykiss, J Immunol 191(12) (2013) 5959-72. [27] B. Huang, W.X. Li, Z.X. Wang, Y. Liang, W.S. Huang, P. Nie, Identification of a novel splice variant isoform of interferon regulatory factor 10, IRF10, in orange spotted grouper Epinephelus coioides, Fish Shellfish Immunol 97 (2020) 637-647. [28] F.F. Lee, H.C. Chuang, N.Y. Chen, G. Nagarajan, P.P. Chiou, Toll-Like Receptor 9 Alternatively Spliced Isoform Negatively Regulates TLR9 Signaling in Teleost Fish, PLoS One 10(5) (2015) e0126388. [29] J. Dekker, A.S. Belmont, M. Guttman, V.O. Leshyk, J.T. Lis, S. Lomvardas, L.A. Mirny, C.C. O'Shea, P.J. Park, B. Ren, J.C.R. Politz, J. Shendure, S. Zhong, D.N. Network, The 4D nucleome project, Nature 549(7671) (2017) 219-226. [30] E.P. Consortium, The ENCODE (ENCyclopedia Of DNA Elements) Project, Science 306(5696) (2004) 636-40. [31] K. Miura, An Overview of Current Methods to Confirm Protein-Protein Interactions, Protein Pept Lett 25(8) (2018) 728-733. [32] V.S. Rao, K. Srinivas, G.N. Sujini, G.N. Kumar, Protein-protein interaction detection: methods and analysis, Int J Proteomics 2014 (2014) 147648. [33] B. Schwikowski, P. Uetz, S. Fields, A network of protein-protein interactions in yeast, Nat Biotechnol 18(12) (2000) 1257-61. [34] H.W. Lee, T. Kyung, J. Yoo, T. Kim, C. Chung, J.Y. Ryu, H. Lee, K. Park, S. Lee, W.D. Jones, D.S. Lim, C. Hyeon, W.D. Heo, T.Y. Yoon, Real-time single-molecule co-immunoprecipitation analyses reveal cancer-specific Ras signalling dynamics, Nat Commun 4 (2013) 1505. [35] R.A. Craig, L. Liao, Phylogenetic tree information aids supervised learning for predicting protein-protein interaction based on distance matrices, BMC Bioinformatics 8 (2007) 6. [36] J. Jumper, R. Evans, A. Pritzel, T. Green, M. Figurnov, O. Ronneberger, K. Tunyasuvunakool, R. Bates, A. Zidek, A. Potapenko, A. Bridgland, C. Meyer, S.A.A. Kohl, A.J. Ballard, A. Cowie, B. Romera-Paredes, S. Nikolov, R. Jain, J. Adler, T. Back, S. Petersen, D. Reiman, E. Clancy, M. Zielinski, M. Steinegger, M. Pacholska, T. Berghammer, S. Bodenstein, D. Silver, O. Vinyals, A.W. Senior, K. Kavukcuoglu, P. Kohli, D. Hassabis, Highly accurate protein structure prediction with AlphaFold, Nature 596(7873) (2021) 583-589. [37] M.D. Giraldez, D. Carneros, C. Garbers, S. Rose-John, M. Bustos, New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology, Nat Rev Gastroenterol Hepatol 18(11) (2021) 787-803. [38] D. Briukhovetska, J. Dorr, S. Endres, P. Libby, C.A. Dinarello, S. Kobold, Interleukins in cancer: from biology to therapy, Nat Rev Cancer 21(8) (2021) 481-499. [39] 陳信宏, 點帶石斑魚介白素-6之基因選殖、蛋白表現及功能分析, 生物科技研究所碩博士班, 國立成功大學, 台南市, 2011, p. 108. [40] 蘇建宏, 在不同免疫刺激下點帶石斑其IL-6, IL-6R和gp130的訊息傳遞, 生物科技研究所, 國立成功大學, 台南市, 2015, p. 117. [41] 莊婷淯, 點帶石斑之Interleukin-6 receptor (IL-6R) 的基因選殖分析及其與Interleukin-6 (IL-6) 融合蛋白的建構與蛋白表現, 獸醫學研究所, 國立臺灣大學, 台北市, 2020, p. 63. [42] 許蕙齡, 點帶石斑(Epinephelus coioides)之glycoprotein130 (gp130)基因選殖,細胞外片段重組蛋白表現及抗血清製作, 漁業科學研究所, 國立臺灣大學, 台北市, 2020, p. 80. [43] T.A. Kunkel, Rapid and efficient site-specific mutagenesis without phenotypic selection, Proc Natl Acad Sci U S A 82(2) (1985) 488-92. [44] R. Breathnach, C. Benoist, K. O'Hare, F. Gannon, P. Chambon, Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries, Proc Natl Acad Sci U S A 75(10) (1978) 4853-7. [45] N.E. Labrou, Protein purification: an overview, Methods Mol Biol 1129 (2014) 3-10. [46] J.A. Bornhorst, J.J. Falke, Purification of proteins using polyhistidine affinity tags, Methods Enzymol 326 (2000) 245-54. [47] P. Braun, A.C. Gingras, History of protein-protein interactions: from egg-white to complex networks, Proteomics 12(10) (2012) 1478-98. [48] P. Bryant, G. Pozzati, A. Elofsson, Improved prediction of protein-protein interactions using AlphaFold2, Nat Commun 13(1) (2022) 1265. [49] 蔡庚呈, 利用螢光共振能量轉移技術 (FRET) 證明點帶石斑魚TNF-α1及TNF-α2之間的交互作用, 生物科技研究所, 國立成功大學, 台南市, 2016, p. 107. [50] Y. Wu, Q. Li, X.Z. Chen, Detecting protein-protein interactions by Far western blotting, Nat Protoc 2(12) (2007) 3278-84. [51] J.M. Kavran, D.J. Leahy, Coupling antibody to cyanogen bromide-activated sepharose, Methods Enzymol 541 (2014) 27-34. [52] Detection of protein-protein interactions using the GST fusion protein pull-down technique, Nature Methods 1(3) (2004) 275-276. [53] G. Skiniotis, M.J. Boulanger, K.C. Garcia, T. Walz, Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor, Nat Struct Mol Biol 12(6) (2005) 545-51. [54] X. Wang, Y. Guo, C. Wen, M. Lv, N. Gan, H. Zhou, A. Zhang, K. Yang, Molecular characterization of grass carp interleukin-6 receptor and the agonistic activity of its soluble form in head kidney leucocytes, Fish Shellfish Immunol 86 (2019) 1072-1080. [55] K. Zhu, X.J. Lu, L. Jian-Fei, J. Chen, The interleukin-6 regulates the function of monocytes/macrophages (MO/Mcapital EF, Cyrillic) via the interleukin-6 receptor beta in ayu (Plecoglossus altivelis), Fish Shellfish Immunol 93 (2019) 191-199. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/85564 | - |
| dc.description.abstract | 介白素-6 (IL-6)是一種多功能性細胞激素，作為細胞間負責聯絡功能的蛋白質，影響細胞活化、增殖與分化等反應。在哺乳類IL-6機制研究當中，IL-6與介白素-6受體(IL-6R)及傳訊分子醣蛋白130 (gp130)組成六聚體複合物以調控生化反應，然而IL-6可依據與膜上型或游離型IL-6R結合而分為古典路徑及替代路徑，藉此發揮其眾多功能。魚類IL-6研究方面目前則多偏向分子選殖與功能分析，先前研究證實魚類IL-6具抑制病原感染擴散與促進抗體保護的效果，也確實能誘發魚體免疫反應如抗菌胜肽表現並降低魚隻遭受細菌及病毒感染的死亡率，未來有機會應用於水生生物疾病防治並作為疫苗佐劑或免疫促進劑。 本篇研究為探討魚類IL-6作用機制與功能，先透過載體重構、訊號胜肽移除、重新篩選單一菌落、基因序列點突變方式突破先前點帶石斑IL-6R與gp130膜外全長蛋白表現與純化之困境，接著透過原核蛋白表現系統、親和性管柱純化法及磁珠純化法取得點帶石斑IL-6、IL-6R、gp130膜外全長及Hyper IL-6純化蛋白，接著透過遠端西方墨點法、親和性層析法與蛋白拉下實驗來測試蛋白質間交互作用，實驗結果顯示點帶石斑IL-6、IL-6R與gp130膜外全長間具有蛋白質交互作用結合關係，此外也從石斑組織中選殖出IL-6R異構型，並進一步探討其可能形成原因為mRNA替代性剪接，另已製備石斑IL-6R及其異構型血清抗體，可用於未來探討及解釋更多石斑IL-6R異構型之生物功能。 本研究為第一篇提出魚類IL-6、IL-6R與gp130蛋白質間交互作用及IL-6R異構型的論文，此份結果可串連先前研究中點帶石斑之IL-6、IL-6R及gp130基因選殖、訊息傳遞及免疫功能分析等研究成果，並作為點帶石斑IL-6作用機制探討、水生生物疾病預防及現場應用的參考基礎，期許未來可應用於石斑水產養殖產業，成功降低細菌及病毒感染所帶來的肆虐，有效提升經濟價值。 | zh_TW |
| dc.description.abstract | Interleukin-6 (IL-6) is a multifunctional cytokine. As a protein responsible for communication between cells, it affects responses such as cell activation, proliferation, and differentiation. In the mechanism study of IL-6 in mammals, IL-6 forms a hexameric complex with its receptor IL-6R and the signaling molecule glycoprotein 130 (gp130) to regulate biochemical reactions. This complex performs many functions by activating different signaling mechanisms and biochemical functions such as classical pathway and alternative pathway. However, few studies have explored the biochemical function of fish IL-6. Previous studies have confirmed that fish IL-6 has the effect of inhibiting the spread of infection and promoting antibody protection. IL-6 also induce immune responses such as antimicrobial peptides and reduce the mortality of fish from bacterial and viral infections. Fish IL-6 research will have the opportunity to be practically applied for disease control and become an adjuvant or immune booster in the future. In this study, targeted protein expression and purification were solved using vector reconstruction, signal peptide removal, re-screening of single colonies, point mutation, and then the targeted protein were expressed through the prokaryotic protein expression system, and then the affinity column was used to obtain the purified proteins of grouper IL-6, IL-6R, gp130 and Hyper IL-6. Then, the interaction between proteins were tested by far western blotting, affinity chromatography and protein pull-down assay. The experimental results show that there are protein interactions between IL-6, IL-6R and gp130 of grouper. In addition, IL-6R isoform was also cloned from grouper tissue, and the possible cause of this formation was further explored as mRNA alternative splicing. Serum antibodies of grouper IL-6R and its isoform have been prepared, which can be used to explore and explain more biological functions of grouper IL-6R isoforms in the future. This is the first thesis to propose the protein-protein interactions between IL-6, IL-6R and gp130 and discovery of IL-6R isoform in fish. This result can be linked to previous research of grouper IL-6, IL-6R and gp130 in our laboratory including gene cloning, signal pathway transduction, immune function analysis and other related research results. The result also be a reference basis for the mechanism study of grouper IL-6, disease prevention and field application. It is expected that it can be applied to the grouper aquaculture industry to reduce the spread of diseases that caused by pathogens infection and effectively enhance economic value in the future. | en |
| dc.description.provenance | Made available in DSpace on 2023-03-19T23:18:41Z (GMT). No. of bitstreams: 1 U0001-1005202215140600.pdf: 15076578 bytes, checksum: 2ab66daa24d5e7b48939904704df102f (MD5) Previous issue date: 2022 | en |
| dc.description.tableofcontents | 目錄 I 謝辭 V 中文摘要 VI 英文摘要 VII 一、介紹 1 1.1 IL-6、IL-6R與gp130 1 1.2 魚類IL-6 2 1.3 IL-6R異構型 4 1.4 蛋白質交互作用 5 1.5 研究動機與目的 6 二、材料與方法 8 2.1 總覽 8 2.2 石斑IL-6R載體重構 8 2.3 石斑gp130膜外全長移除訊號胜肽 14 2.4 石斑gp130膜外片段蛋白表現修正 18 2.5 蛋白質表現 20 2.6 蛋白質純化 24 2.7 蛋白質定量與濃縮 26 2.8 蛋白質交互作用 28 2.9 石斑IL-6R異構型選殖 31 三、結果 36 3.1 石斑IL-6R載體重構 36 3.2 石斑gp130膜外全長移除訊號胜肽 36 3.3 石斑gp130膜外片段蛋白表現修正 37 3.4 蛋白質表現與純化 37 3.5 蛋白質交互作用 37 3.6 石斑IL-6R異構型選殖 38 四、討論 40 4.1 蛋白質純化問題修正探討 40 4.2 蛋白質交互作用測試方法探討 40 4.3 石斑之IL-6、IL-6R與gp130交互作用探討 42 4.4 石斑之IL-6R異構型探討 43 4.5 研究結論 44 五、參考文獻 45 六、圖表 54 圖一、石斑IL-6R載體重構與gp130膜外全長移除訊號胜肽限制酶切割結果 54 圖二、石斑IL-6R載體重構菌落PCR結果 55 圖三、石斑gp130膜外全長訊號胜肽預測結果 56 圖四、PCR擴增獲取移除訊號胜肽之石斑gp130膜外全長基因 57 圖五、石斑gp130膜外全長移除訊號胜肽菌落PCR結果 58 圖六、石斑gp130膜外片段1蛋白表現修正 59 圖七、石斑gp130膜外片段3蛋白表現修正 60 圖八、石斑gp130膜外片段5蛋白表現修正 61 圖九、石斑IL-6蛋白表現與純化 62 圖十、石斑IL-6R蛋白表現與純化 63 圖十一、石斑Hyper IL-6蛋白表現與純化 64 圖十二、石斑gp130膜外全長蛋白表現與純化 65 圖十三、石斑IL-6與IL-6R間蛋白質交互作用(遠端西方墨點法) 66 圖十四、石斑IL-6與IL-6R間蛋白質交互作用(親和性層析法) 67 圖十五、石斑IL-6R與gp130膜外全長蛋白質交互作用(蛋白拉下實驗) 68 圖十六、石斑IL-6與gp130膜外全長蛋白質交互作用(蛋白拉下實驗) 69 圖十七、石斑Hyper IL-6與膜外全長gp130蛋白質交互作用(蛋白拉下實驗) 70 圖十八、石斑CTSL與gp130膜外全長蛋白質交互作用(蛋白拉下實驗) 71 圖十九、石斑il-6r異構型cDNA瓊脂糖膠體電泳分析 72 圖二十、石斑il-6r異構型開放閱讀框架cDNA序列及預測胺基酸序列 73 圖二十一、石斑il-6r異構型基因序列於NCBI資料庫比對結果 74 圖二十二、石斑IL-6R異構型胺基酸序列於NCBI資料庫比對結果 75 圖二十三、mRNA替代性剪接形成石斑il-6r異構型示意圖 76 圖二十四、石斑il-6r第2段與第3段外顯子及前後內含子邊界序列 77 表一、目標蛋白質表現與純化條件 78 表二、引子資訊 79 七、附錄 80 附錄一、哺乳類IL-6、IL-6R及gp130結合圖 80 附錄二、哺乳類IL-6與IL-6R及gp130結合方式及傳訊路徑圖 81 附錄三、pET-24a載體圖 82 附錄四、pET-28b載體圖 83 附錄五、pGEM-T Easy載體圖 84 附錄六、石斑gp130膜外片段之分段設計圖 85 附錄七、mRNA替代性剪接常見種類 86 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 介白素-6受體 | zh_TW |
| dc.subject | 點帶石斑魚 | zh_TW |
| dc.subject | 蛋白質交互作用 | zh_TW |
| dc.subject | 醣蛋白130 | zh_TW |
| dc.subject | 介白素-6受體 | zh_TW |
| dc.subject | 介白素-6 | zh_TW |
| dc.subject | 點帶石斑魚 | zh_TW |
| dc.subject | 蛋白質交互作用 | zh_TW |
| dc.subject | 醣蛋白130 | zh_TW |
| dc.subject | 介白素-6 | zh_TW |
| dc.subject | protein-protein interactions | en |
| dc.subject | interleukin-6 | en |
| dc.subject | Epinephelus coioides | en |
| dc.subject | interleukin-6 receptor | en |
| dc.subject | glycoprotein 130 | en |
| dc.subject | protein-protein interactions | en |
| dc.subject | Epinephelus coioides | en |
| dc.subject | glycoprotein 130 | en |
| dc.subject | interleukin-6 receptor | en |
| dc.subject | interleukin-6 | en |
| dc.title | 點帶石斑之介白素-6、介白素-6受體與醣蛋白130間蛋白質交互作用探討及介白素-6受體異構型選殖 | zh_TW |
| dc.title | Protein-Protein Interactions between Interleukin-6, Interleukin-6 Receptor and Glycoprotein 130 as well as Cloning of IL-6R Isoform of Epinephelus coioides | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 110-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 陳歷歷;邱品文 | zh_TW |
| dc.contributor.oralexamcommittee | Li-Li Chen;Pin-Wen Giumj | en |
| dc.subject.keyword | 介白素-6,介白素-6受體,醣蛋白130,蛋白質交互作用,點帶石斑魚, | zh_TW |
| dc.subject.keyword | interleukin-6,interleukin-6 receptor,glycoprotein 130,protein-protein interactions,Epinephelus coioides, | en |
| dc.relation.page | 86 | - |
| dc.identifier.doi | 10.6342/NTU202200758 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2022-07-05 | - |
| dc.contributor.author-college | 生物資源暨農學院 | - |
| dc.contributor.author-dept | 獸醫學系 | - |
| dc.date.embargo-lift | 2027-07-03 | - |
| 顯示於系所單位： | 獸醫學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-110-2.pdf 此日期後於網路公開 2027-07-03 | 14.72 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。